Radiology Partners' Cognita Chest X-ray AI tool earns FDA Breakthrough Device status for multiple clinical uses.
Key Details
- 1Radiology Partners' Cognita business received FDA Breakthrough Device designation for its Chest X-ray AI tool.
- 2The tool uses a generative vision-language model to assist radiologists in X-ray interpretation.
- 3This is among the first vision-language AI solutions in radiology to receive this designation.
- 4Breakthrough status expedites regulatory review for devices addressing critical needs.
- 5Cognita CXR integrates into radiology workflows to generate comprehensive preliminary reports for physician review.
Why It Matters
FDA Breakthrough Device designation is a major step for AI-driven radiology tools, signaling both clinical promise and regulatory progress. This can accelerate the path toward broader clinical deployment of advanced AI models in everyday radiology practice.
Source
Radiology Business
Related News
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.
•AuntMinnie
Radiologists Share Insights on Boosting Workflow with AI at SIIM
Dr. Nina Kottler discusses strategies for leveraging AI to improve radiology workflow efficiency at SIIM 2026.
•AuntMinnie
ONC Official at SIIM Calls for Smarter AI and Better Image Sharing
ONC's Dr. Jason Funderburk urges improvements in medical image sharing and AI readiness at SIIM 2024.